Danny Eckert, PhD (Australia)
Mathew Flinders Professor and Director, Adelaide Institute for Sleep Health
Flinders University, South Australia
Keynote Summary: This presentation will cover the latest knowledge of the different OSA endotypes and their role in advancing OSA pathogenesis and treatment. This will include development of new targeted therapies including combination therapy and pharmacotherapy, optimisation of existing therapies and clinically practical techniques to estimate OSA endotypes to deliver precision medicine for OSA at scale.
Biosketch: Dr. Eckert is a National Health and Medical Research Council of Australia Senior Research Fellow and a Mathew Flinders Professor at Flinders University in Adelaide, South Australia. He currently serves as Director of the Adelaide Institute for Sleep Health and Deputy Director and Theme Lead of Clinical Translation at the Flinders Health and Medical Research Institute. Professor Eckert leads a comprehensive basic sciences and translational research program that focuses on identification of the causes of sleep apnea, optimisation of existing therapies, and development of new tailored therapies. He is most well-known for his pioneering respiratory phenotyping work which has led to a new precision medicine therapeutic framework to understand and treat OSA and for his research on the role of arousal mechanisms on sleep apnea pathogenesis and novel pharmacotherapy. He has published ~150 articles in the leading sleep and respiratory medicine and other cross-disciplinary and general medical journals. His previous appointments include Professor of Medicine at the University of New South Wales in Sydney, Principal Research Scientist at Neuroscience Research Australia, and Assistant Professor within the Division of Sleep Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston.